CVC Capital Partners has received a binding offer from Sika, a Switzerland-based speciality chemicals company, for Parex, a France-headquartered dry-mix building materials maker, valuing it at $2.55bn (CHF 2.5bn).
GPs will sell their entire interest in the share capital of Altran for €14 per share
Vendors Zwanenberg and René Hochstenbach will retain minority stakes following the acquisition
Fund will target seed and series-A opportunities in technology sectors across Europe
Company plans to increase its revenues and to double its network of clinics by 2021